Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vomiting
Clinical narrative: Mild malaise/feeling sick and no interference with activity; Joint pain and no interference with activity; Mild muscle pain and no interference with activity; Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting; Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting; Mild fatigue and no interference with activity; Mild injection site redness; Mild injection site swelling; Mild injection site pain and no interference with activity /Mild injection site tenderness (tender to touch); This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Mild malaise/feeling sick and no interference with activity), ARTHRALGIA (Joint pain and no interference with activity), MYALGIA (Mild muscle pain and no interference with activity), VOMITING (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting) and NAUSEA (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In January 2024, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In January 2024, the patient experienced MALAISE (Mild malaise/feeling sick and no interference with activity), ARTHRALGIA (Joint pain and no interference with activity), MYALGIA (Mild muscle pain and no interference with activity), VOMITING (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting), NAUSEA (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting), FATIGUE (Mild fatigue and no interference with activity), VACCINATION SITE ERYTHEMA (Mild injection site redness), VACCINATION SITE SWELLING (Mild injection site swelling) and VACCINATION SITE PAIN (Mild injection site pain and no interference with activity /Mild injection site tenderness (tender to touch)). At the time of the report, MALAISE (Mild malaise/feeling sick and no interference with activity), ARTHRALGIA (Joint pain and no interference with activity), MYALGIA (Mild muscle pain and no interference with activity), VOMITING (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting), NAUSEA (Mild nausea/vomiting and no interference with activity or 1-2 episodes of nausea/vomiting), FATIGUE (Mild fatigue and no interference with activity), VACCINATION SITE ERYTHEMA (Mild injection site redness), VACCINATION SITE SWELLING (Mild injection site swelling) and VACCINATION SITE PAIN (Mild injection site pain and no interference with activity /Mild injection site tenderness (tender to touch)) outcome was unknown.            (Privacy) Subject ID was reported. (Privacy) Subject ID was reported.  Concomitant medication information was not reported.  The patient experienced events anytime during the 2 days after COVID-19 vaccination, which occurred on 29-Jan-2024 and 30-Jan-2024.  Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2024-759560 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-759560:Same reporter, Master case